HISTORY
The European Association of Dermato-Oncology (EADO) was founded in 1998 in Kaysersberg/Alsace in France on the initiative of Hubert Pehamberger from Vienna (first president), Jean Jacques Grob from Marseille (second president) and Claus Garbe from Tübingen (third president) as well as other participants from Austria, France and Germany. Josep Malvehy from Barcelona is the fourth President of the EADO since April 2025.
The EADO is an independent non-profit organization dedicated to promote, coordinate and improve clinical and laboratory research activities in the field of skin cancer including primary and secondary prevention, early detection, clinical diagnosis and clinical and experimental research. Over the years we have made great progress in standardizing the therapy of skin tumors through European guidelines and have improved the understanding of skin tumors with our research projects and studies. Our focus is on improving early detection, therapy and follow-up of our patients.
Today, the EADO has more than 1,700 members from 89 different countries. The board consists of 30 representatives from 18 countries.
MISSION
Guidelines
The EADO provides leadership by formulating and disseminating quality standards and guidelines for diagnosis and treatment of skin cancer.
Trials
The EADO provides direction, coordination and organisations of clinical, therapeutical and experimental trials in the area of skin cancer.
Education
The EADO supports and organises meetings dedicated to the presentation of new research findings, exchange of information and education for its members in the field of Dermato-Oncology
Projects
The EADO offers coordination and support of projects of the respective national skin cancer groups.
LATEST NEWS
EADO Skin Cancer Centers of Excellence Preceptorship 202616. February 2026- ILDS Membership20. January 2026
- Launch of a Joint EADO–EUMelaReg ctDNA Project13. January 2026
EADO Monthly Insight
Stay informed with the official newsletter of the European Association of Dermato-Oncology. Each month, EADO members receive a concise, informative, and engaging overview of the most important developments in dermato-oncology – including recent scientific publications, clinical advancements, regulatory updates, upcoming events, and news from the EADO community.
Download an excerpt from our latest newsletter. Receive the complete newsletters in our members area. Not yet an EADO member? Join EADO today!
Excerpt from EADO Monthly Insight 3/2026JOIN THE EADO ASSOCIATION
EADO Members receive the EADO News, reduced fees for EADO Congresses, access to the presentations from past EADO scientific meetings and more!
Not yet a member? Become a member now!Launch of a Joint EADO–EUMelaReg ctDNA Project
On behalf of EADO, we are pleased to announce the launch of a joint EADO–EUMelaReg project aimed at integrating circulating tumor DNA (ctDNA) into routine melanoma follow-up. The project will evaluate the clinical utility of ctDNA assessed using Oncobit’s CE-IVDR–marked digital PCR solution to detect relapse and to complement or potentially replace established monitoring approaches. By closely reflecting real-world clinical practice and leveraging the strengths of the EUMelaReg registry, this initiative seeks to advance precision monitoring in melanoma care.
Key aspects of the project include:
- ctDNA testing would be conducted as part of clinical routine, similar to established markers such as LDH and S100.
- This is permissible as a CE-marked (IVDR-compliant) test, OncobitTM PM, is used.
- When performed within routine diagnostics, results can be reported directly to patients.
- All resulting clinical and ctDNA data can subsequently be entered into the EUMelaReg registry.
- A consolidated readout from the registry can then be performed at a dedicated time point (similar to other EUMelaReg publications).
Please reach out to Prof. Dr. Reinhard Dummer or Dr. Claudia Scheckel for more information.
ILDS MEMBER
We are proud to be a member of the International League of Dermatological Societies (ILDS). Under the vision of “Skin Health for the World”, the ILDS represents dermatology globally and works to ensure that skin health is recognised in global health policy.
Avoid sunbathing and tanning!
Skin cancers are the most frequent cancers in fair-skinned populations, but we can prevent them – European Journal of Cancer, May 2024
More